These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 8601365)

  • 1. Effects of ursodiol or ibuprofen on contraction of gallbladder and bile among obese patients during weight loss.
    Marks JW; Bonorris GG; Schoenfield LJ
    Dig Dis Sci; 1996 Feb; 41(2):242-9. PubMed ID: 8601365
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prevention of gallstone formation in morbidly obese patients undergoing rapid weight loss: results of a randomized controlled pilot study.
    Wudel LJ; Wright JK; Debelak JP; Allos TM; Shyr Y; Chapman WC
    J Surg Res; 2002 Jan; 102(1):50-6. PubMed ID: 11792152
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The role of gallbladder emptying in gallstone formation during diet-induced rapid weight loss.
    Gebhard RL; Prigge WF; Ansel HJ; Schlasner L; Ketover SR; Sande D; Holtmeier K; Peterson FJ
    Hepatology; 1996 Sep; 24(3):544-8. PubMed ID: 8781321
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gallbladder motility and gallstone formation in obese patients following very low calorie diets. Use it (fat) to lose it (well).
    Festi D; Colecchia A; Orsini M; Sangermano A; Sottili S; Simoni P; Mazzella G; Villanova N; Bazzoli F; Lapenna D; Petroni ML; Pavesi S; Neri M; Roda E
    Int J Obes Relat Metab Disord; 1998 Jun; 22(6):592-600. PubMed ID: 9665682
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Changes in biliary lipid secretion and cholic acid kinetics induced by diet, diet plus simvastatin and diet plus ursodeoxycholic acid in obese subjects.
    Mazzella G; Cipolla A; Villanova N; Polimeni C; Sipahi A; Parini P; Fusaroli P; Festi D; Roda E
    Ital J Gastroenterol; 1995; 27(8):441-5. PubMed ID: 8775472
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of ursodeoxycholic acid and aspirin on the formation of lithogenic bile and gallstones during loss of weight.
    Broomfield PH; Chopra R; Sheinbaum RC; Bonorris GG; Silverman A; Schoenfield LJ; Marks JW
    N Engl J Med; 1988 Dec; 319(24):1567-72. PubMed ID: 3200265
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gallbladder motility and lithogenesis in obese patients during diet-induced weight loss.
    Zapata R; Severín C; Manríquez M; Valdivieso V
    Dig Dis Sci; 2000 Feb; 45(2):421-8. PubMed ID: 10711462
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Estimation of the cost savings resulting from the use of ursodiol for the prevention of gallstones in obese patients undergoing rapid weight reduction.
    Shoheiber O; Biskupiak JE; Nash DB
    Int J Obes Relat Metab Disord; 1997 Nov; 21(11):1038-45. PubMed ID: 9368828
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prophylaxis against gallstone formation with ursodeoxycholic acid in patients participating in a very-low-calorie diet program.
    Shiffman ML; Kaplan GD; Brinkman-Kaplan V; Vickers FF
    Ann Intern Med; 1995 Jun; 122(12):899-905. PubMed ID: 7755224
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparative evaluation of chenodeoxycholic and ursodeoxycholic acids in obese patients. Effects on biliary lipid metabolism during weight maintenance and weight reduction.
    Mazzella G; Bazzoli F; Festi D; Ronchi M; Aldini R; Roda A; Grigolo B; Simoni P; Villanova N; Roda E
    Gastroenterology; 1991 Aug; 101(2):490-6. PubMed ID: 2065925
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Effects of fiber administration in the prevention of gallstones in obese patients on a reducing diet. A clinical trial].
    Morán S; Uribe M; Prado ME; de la Mora G; Muñoz RM; Pérez MF; Milke P; Blancas JM; Dehesa M
    Rev Gastroenterol Mex; 1997; 62(4):266-72. PubMed ID: 9580234
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Natural history and treatment with ursodiol of gallstones formed during rapid loss of weight in man.
    Marks JW; Stein T; Schoenfield LJ
    Dig Dis Sci; 1994 Sep; 39(9):1981-4. PubMed ID: 8082507
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effect of ursodeoxycholic acid on nucleation time in patients with solitary or multiple gallbladder stones.
    Tudyka J; Wechsler JG; Mason R; Maier C
    Am J Gastroenterol; 1994 Aug; 89(8):1206-10. PubMed ID: 8053436
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cisapride improves gallbladder emptying and bile lipid composition in patients with gallstones.
    Dhiman RK; Reddi R; Sharma A; Singh R; Kohli KK; Gupta S; Suri S; Chawla Y
    J Gastroenterol Hepatol; 2001 Jul; 16(7):816-20. PubMed ID: 11446892
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of ursodeoxycholic acid therapy on in vitro gallbladder contractility in patients with cholesterol gallstones.
    van de Heijning BJ; van de Meeberg PC; Portincasa P; Doornewaard H; Hoebers FJ; van Erpecum KJ; Vanberge-Henegouwen GP
    Dig Dis Sci; 1999 Jan; 44(1):190-6. PubMed ID: 9952243
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ursodeoxycholic acid reduces lipid peroxidation and mucin secretagogue activity in gallbladder bile of patients with cholesterol gallstones.
    Jüngst C; Sreejayan N; Zündt B; Müller I; Spelsberg FW; Hüttl TP; Kullak-Ublick GA; del Pozo R; Jüngst D; von Ritter C
    Eur J Clin Invest; 2008 Sep; 38(9):634-9. PubMed ID: 18837739
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effect of ursodeoxycholic acid therapy on gallstone formation in the morbidly obese during rapid weight loss.
    Worobetz LJ; Inglis FG; Shaffer EA
    Am J Gastroenterol; 1993 Oct; 88(10):1705-10. PubMed ID: 8213711
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The sequence of biliary events preceding the formation of gallstones in humans.
    Marks JW; Bonorris GG; Albers G; Schoenfield LJ
    Gastroenterology; 1992 Aug; 103(2):566-70. PubMed ID: 1634075
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ursodeoxycholic acid reduces protein levels and nucleation-promoting activity in human gallbladder bile.
    Van Erpecum KJ; Portincasa P; Eckhardt E; Go PM; VanBerge-Henegouwen GP; Groen AK
    Gastroenterology; 1996 Apr; 110(4):1225-37. PubMed ID: 8613013
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of ursodeoxycholic acid on gallbladder contraction and cholecystokinin release in gallstone patients and normal subjects.
    van Erpecum KJ; van Berge Henegouwen GP; Stolk MF; Hopman WP; Jansen JB; Lamers CB
    Gastroenterology; 1990 Sep; 99(3):836-42. PubMed ID: 2199291
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.